Save time and get answers to complex questions with AI chat
Drugpatentwatch market analysis industry today?Mebendazole ingredients?Is guselkumab off patent in u s?Guselkumab brand name?Campath litigation germany?
See the DrugPatentWatch profile for aspirin
Short answer: No, aspirin doesn’t add extra heart‑protection to Vascepa, and it can even raise bleeding risk.
These pathways act independently, so taking both together doesn’t create a synergistic heart‑protective effect.
ACC/AHA 2023 Guideline on Hypertriglyceridemia: Recommends 4 g/day of EPA (Vascepa) for patients with ASCVD who remain high‑risk despite maximally tolerated statin therapy. Aspirin is not added to this recommendation, and its use is considered separately for secondary prevention.
European guidelines: Similar stance—EPA therapy is independent of aspirin use.
Feel free to ask if you’re unsure whether your particular medication plan is right for you!
Other Questions About Aspirin :